Keep copies of everything submitted
Natco Pharma has moved the Delhi High Court seeking revocation of Novo Nordisks Indian patent on semaglutide, the active ingredient behind global brands like Ozempic and Wegovy
At 1 mg/mL, 100 units equals just 1 mg, a moderate dose within normal protocols
With the loss of exclusivity, several companies, including Sandoz, Apotex, Teva, Taro, Vimy Pharma, Hims & Hers, and Biocon, have filed applications to launch generic versions of semaglutide, but they are pending Health Canadas regulatory approval
These findings largely align with whats been seen with tirzepatide and other GLP-1based medications, including small risks of pancreatitis and gallbladder issues, dose-related gastrointestinal side effects, and discontinuation due to tolerability
Related Research Compounds Tirzepatide (TIRZ) is commonly compared against other incretin and metabolic research peptides